Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...

Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told ...

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could ...

Kenvue shares rebounded after a sharp fall triggered by Donald Trump's unfounded claims linking Tylenol to autism. Trump ...

Kenvue stock dropped following reports of a possible autism link to Tylenol's active ingredient, acetaminophen. Federal ...

The Trump administration's warning could potentially lead to more lawsuits against Kenvue ( NYSE: KVUE ), alleging that ...

Tylenol maker Kenvue ‘strongly disagrees’ there is a causal link between acetaminophen use during pregnancy and autism.

Trump's advice for pregnant women to avoid Tylenol alarmed doctors. A lack of scientific proof for his claims sent Kenvue's shares higher ...

Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.

Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.” ...

Tylenol maker Kenvue’s stock rose 6.01% in premarket trading on September 23 to $17.99. The recovery followed the severe 7.47 ...

Shares of Kenvue Inc. sank 7.5 percent on Monday as President Trump linked use of the painkiller by pregnant woman with autism in children.